Coloplast A/S (CLPBY)
12.56
+0.20
(+1.62%)
USD |
OTCM |
May 17, 16:00
Coloplast Total Assets (Quarterly): 6.964B for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 6.964B |
| December 31, 2023 | 7.214B |
| September 30, 2023 | 6.821B |
| June 30, 2023 | 5.120B |
| March 31, 2023 | 5.168B |
| December 31, 2022 | 5.069B |
| September 30, 2022 | 4.949B |
| June 30, 2022 | 4.940B |
| March 31, 2022 | 5.278B |
| December 31, 2021 | 2.464B |
| September 30, 2021 | 2.471B |
| June 30, 2021 | 2.474B |
| March 31, 2021 | 2.404B |
| December 31, 2020 | 2.467B |
| September 30, 2020 | 2.128B |
| June 30, 2020 | 2.009B |
| March 31, 2020 | 1.998B |
| December 31, 2019 | 1.982B |
| September 30, 2019 | 1.866B |
| June 30, 2019 | 1.912B |
| March 31, 2019 | 1.847B |
| December 31, 2018 | 1.856B |
| September 30, 2018 | 1.831B |
| June 30, 2018 | 1.965B |
| March 31, 2018 | 2.108B |
| Date | Value |
|---|---|
| December 31, 2017 | 1.965B |
| September 30, 2017 | 1.907B |
| June 30, 2017 | 1.884B |
| March 31, 2017 | 1.797B |
| December 31, 2016 | 1.832B |
| September 30, 2016 | 1.657B |
| June 30, 2016 | 1.687B |
| March 31, 2016 | 1.612B |
| December 31, 2015 | 1.583B |
| September 30, 2015 | 1.632B |
| June 30, 2015 | 1.495B |
| March 31, 2015 | 1.540B |
| December 31, 2014 | 1.578B |
| September 30, 2014 | 1.769B |
| June 30, 2014 | 1.669B |
| March 31, 2014 | 1.708B |
| December 31, 2013 | 1.555B |
| September 30, 2013 | 1.730B |
| June 30, 2013 | 1.509B |
| March 31, 2013 | 1.730B |
| December 31, 2012 | 1.732B |
| September 30, 2012 | 1.762B |
| June 30, 2012 | 1.670B |
| March 31, 2012 | 1.664B |
| December 31, 2011 | 1.554B |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
1.866B
Minimum
Sep 2019
7.214B
Maximum
Dec 2023
3.785B
Average
2.473B
Median
Total Assets (Quarterly) Benchmarks
| Genmab A/S | 5.306B |
| Ascendis Pharma A/S | 866.62M |
| Galecto Inc | 32.48M |
| Evaxion Biotech AS | 12.89M |
| IO Biotech Inc | 128.16M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 4.620B |
| Shareholders Equity (Quarterly) | 2.343B |
| Debt to Equity Ratio | 1.449 |
| Current Ratio | 0.6005 |
| Net Debt Paydown Yield | -0.21% |